| Outgoing Relation(s) |
| sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) is a biochemical role (CHEBI:52206) |
| sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) is a inhibitor (CHEBI:35222) |
| Incoming Relation(s) |
| bexagliflozin (CHEBI:229225) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| canagliflozin (CHEBI:73274) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| canagliflozin hydrate (CHEBI:73272) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| dapagliflozin (CHEBI:85078) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| dapagliflozin propanediol monohydrate (CHEBI:85079) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| empagliflozin (CHEBI:82720) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| sotagliflozin (CHEBI:229226) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| Synjardy (CHEBI:90875) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
| TA-1887 (CHEBI:229237) has role sodium-glucose transport protein subtype 2 inhibitor (CHEBI:73273) |
